ORGANIZATION AND NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2024	Jun. 30, 2025
Financial assets		$ 54,311,892	$ 61,835,560
CANA Pharmaceutical Laboratories, S.A. ("Cana") [Member]
Cash		5,331,120
Fair value of common stock issued	$ 138,667	138,667
Fair value of total consideration transferred		5,469,787
Financial assets		1,796,911
Inventory		297,340
Property, plant and equipment		7,488,818
Identifiable intangible assets		562,200
Financial liabilities		(3,235,233)
Total identifiable net assets		6,910,036
Bargain purchase gain		$ 1,440,249